What should be the core outcomes in chronic pain clinical trials?

Arthritis Research and Therapy

Volumn 6, Issue 4, 2004, Pages 151-154

  Turk, Dennis C ^a   Dworkin, Robert H ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Chronic pain; Clinical trials; Outcomes; Patient global ratings; Quality of life

Indexed keywords

ANALGESIC AGENT;

ARTICLE; CHRONIC PAIN; CLINICAL STUDY; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; DRUG INDUSTRY; EMOTION; GOVERNMENT; HEALTH STATUS; HUMAN; MEDICAL EDUCATION; OUTCOMES RESEARCH; PATIENT SATISFACTION; PHYSICAL ACTIVITY; POPULATION RESEARCH; RATING SCALE; SIDE EFFECT; TREATMENT INDICATION; TREATMENT OUTCOME;

CHRONIC DISEASE; CLINICAL TRIALS; EXERCISE MOVEMENT TECHNIQUES; HUMANS; INTERPERSONAL RELATIONS; PAIN; PATIENT SATISFACTION; TREATMENT OUTCOME;

EID: 4444384585     PISSN: 14786354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Abbott FV, Fraser MI: Use and abuse of over-the-counter analgesic agents. J Psychiat Neurosci 1998, 23:13-34.
2. Pleis JR, Coles R: Summary health statistics for U.S. adults: National Health Interview Survey, 1998. National Center for Health Statistics, Vital Health Statistics 2002; 10(209).
3. United States Bureau of the Census: Statistical Abstract of the United States: 1996. 116th edition. Washington DC: US Bureau of the Census; 1996.
4. National Research Council: Musculoskeletal disorders and the workplace. Washington DC: National Academy Press; 2001.
5. Deyo RA, Battie M, Beurskens AHHM, Bombardier C, Croft P, Koes B: Outcome measures for low back pain research. A proposal for standardized use. Spine 1998, 23:2003-2013.
6. Revicki DA: Health care technology assessment and health-related quality of life. In Health Care Technology and Its Assessment: An International Perspective. Edited by Banta D, Luce BR. New York: Oxford University Press; 1993:114-131.
7. Waddell G: The back pain revolution. London: Churchill Livingstone; 1998.
8. Anderson RB, Hollenberg NK, Williams GH: Physical Symptoms Distress Index. A sensitive tool to evaluate the impact of pharmacological agents. Arch Intern Med 1999,159:693-700.
9. Anderson RB, Testa MA: Symptom distress checklists as a component of quality of life measurement: comparing prompted reports by patient and physician with concurrent adverse event reports via the physician. Drug Inform J 1994, 28:89-114.
10. Moher D, Schulz K, Altman DG for the CONSORT Group: The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 2001, 134:657-662.
11. Bellamy N, Kirwan J, Boers M: Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. J Rheumatol 1997, 24:799-802.